Sourdough Patents: Who Leads, Where the Gaps Are 2026
- 54.8% of all 332 records sit with the top five assignees — filing here means competing directly against entrenched claim positions, not empty space.
- Peak filing was 2019 (43 records) and 2021→2024 shows an -8% shift, a plateau rather than a collapse once the 18-month publication lag is factored in.
- A21D and A23L dominate the IPC mix at 54.5% and 39.8% of records respectively, while cosmetics-use filings under A61Q sit at just 12.0% — a narrower, less-crowded branch.
Filing growth compares 2021 (12 records) with 2024 (11) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 332 records in scope (CR5), not by the ranked leaders only.
What this landscape covers
This dataset tracks 332 published patent families filed between 2015 and mid-2026 that combine sourdough or biological leavening process claims with lactic acid bacteria, starter maintenance, acidification rate, aroma development, dough rheology or process automation language. It spans classical food-science filings on starter cultures and dough handling alongside a substantial overlap into therapeutic and cosmetic use of the same microbial strains. Family-level counting is used throughout so that multi-jurisdiction filing by the same applicant does not inflate the picture.
The receiving-office spread shows Europe and the United States as the primary filing venues, with a meaningful PCT layer and secondary activity in Canada, Australia and Germany — consistent with an industry that files nationally close to production but keeps optionality open through international routes.
Filing trend and technology composition
Two views of the same 332 records: how filing volume has moved year over year, and which IPC subclasses the claims actually sit in.
Filing activity, 2017–2026
Filings rose from 17 in 2017 to a peak of 43 in 2019, then eased back; 2021 to 2024 — the last year that can be read as complete — moved from 12 to 11 records, an -8% shift. 2025 and 2026 figures are still filling in under the roughly 18-month publication lag and should not be read as a decline.
Technology composition by IPC subclass
A21D (baking and doughs) and A23L (foods and non-alcoholic beverages) anchor the field at 54.5% and 39.8% of records. The presence of A61K and A61P at 36.7% and 18.1% signals that a large share of this corpus is claiming therapeutic use of leavening microorganisms, not just food process steps — a cross-over that narrows freedom to operate for anyone treating this as a pure bakery-technology space.
Shares are the percentage of the 332 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Sourdough and Biological Leavening with Eureka
This page is one run against one query. Ask Eureka your own question about sourdough and biological leavening and every answer comes back with the patent numbers behind it.
Try EurekaMost-cited records and a representative recent filing
CA3258861A1 — Processing aid comprising encapsulated sourdough lactic acid bacteria for the preparation of doughs for bakery products
The filing claims an aid for preparing baked-food doughs comprising a food-grade carrier and microcapsules containing viable lactic acid bacteria, enclosed in a casing including at least one gellable biopolymer. The microcapsules are specified by average size range and by mechanical compressive strength, dispersed within food-grade flour.Filed by Il Granaio Delle Idee S.r.l., published 2024-01-11.
View full record| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US20080131556A1 | Mixture of at Least 6 Species of Lactic Acid Bacteria and/or Bifidobacteria in the Manufacture of Sourdough | 126 |
| 2 | WO2006097415A1 | Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough | 46 |
| 3 | WO2000010395A1 | Sourdough product | 35 |
| 4 | WO1994019950A1 | Biocontrol agents for use in agriculture | 28 |
| 5 | WO2013191845A1 | Dietary management of celiac disease and food allergy | 27 |
| 6 | WO2005051102A1 | Process for the fermentative enrichment of foods with fructo-oligosaccharides | 27 |
| 7 | EP0806144A2 | Production of a fluid or pasty biological baking agent for bread using lactic bacteria, as well as the baking… | 26 |
| 8 | CN104255538A | 一种资源化利用畜禽粪便和作物秸秆制备发酵床垫料的工艺 | 25 |
| 9 | US20090246318A1 | composition | 21 |
| 10 | WO2021148974A1 | New strains of lactic acid bacteria, food composition comprising them, preparation of such composition | 17 |
Citation counts favour older filings in any searched corpus; read them as a signal of influence on later filers, not as a measure of current commercial importance.
Patent titles are shown in the language they were filed in, not translated, so that each record stays verifiable against the original filing — a translated title will not match in Eureka or in any national register. Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the data means for filing strategy
Three findings that shape where a new filing has room to stand and where it walks into dense prior art.
The top of the field is genuinely concentrated
More than half of all records in scope belong to five assignees, and the top ten combined reach 72.3% of 332 records. A new entrant filing broad claims on starter culture composition or acidification control is filing directly over occupied ground.
Two early filings anchor the citation graph
The most-cited record, on multi-species lactic acid bacteria and bifidobacteria mixtures for sourdough manufacture, carries 126 citations, with its earlier WO counterpart at 46. Later filers building on multi-strain starter blends are almost certainly citing back to this pair.
Food and pharma claims overlap heavily
A61K and A61P together cover a large minority of this corpus, meaning many sourdough-adjacent filings are structured as therapeutic or health-claim patents rather than pure food-process patents. Freedom-to-operate work here has to check pharma classifications, not just bakery ones.
Volume has plateaued, not collapsed
After peaking at 43 records in 2019, filing eased to a comparatively flat 12-to-11 record range between 2021 and 2024. Given the publication lag, this reads as a mature but still-active field rather than one in decline.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to sourdough and biological leavening, with the prior art for and against each one.
Who is filing, and where the room to move sits
The ranked leaders account for a large share of total volume, but the sub-100-record tail and the co-filing pairs point to where collaboration and gaps both exist.
A single leader well ahead of the field
The top-ranked assignee holds 73 records against a fifth-place figure of 19 and a tenth-place figure of 8 — a steep drop-off that marks this as a leader-and-long-tail market rather than an evenly split one.
A long tail of single- and low-count filers
Beyond the top ten, the ranking spreads across many assignees with small counts each, typical of a field where academic groups, regional bakeries and specialty ingredient houses all file occasionally rather than systematically.
Co-filing is limited but pointed
Only ten co-assignee pairs appear in this corpus; the strongest links pair an ingredients company with a university partner, and a probiotics specialist with two separate collaborators — evidence of applied research partnerships rather than broad industry consortia.
| Assignee | Recent year | YoY |
|---|---|---|
| Giuliani SpA | 0 | — |
| Puratos NV | 0 | — |
| MJN US Holdings LLC | 0 | — |
| GONZALEZ DE LA TORRE JAVIER | 0 | — |
| ISOTHRIVE | 0 | — |
| International N&H Denmark ApS | 0 | — |
| ACTIAL FARM SRL | 0 | — |
| VSL PHARMACEUTICALS INC | 0 | — |
Where to take this next
The landscape points to specific follow-up work depending on whether the goal is freedom-to-operate, licensing or new filing strategy.
Map claims against the leader's portfolio
With 54.8% of records held by the top five assignees, any new filing on starter composition or acidification control should be checked claim-by-claim against the leading assignee's 73-record position first.
Run a freedom-to-operate checkTest the under-claimed branches
Cosmetic-use and process-automation sub-areas show materially lower filing density than the core baking classes, which is where a narrower, well-drafted first claim has the best odds of standing alone.
Explore white space in EurekaCommon questions on this landscape
One assignee leads clearly with 73 records, well ahead of the fifth-ranked assignee at 19 and the tenth at 8. The top five assignees together hold 54.8% of all 332 records in scope, and the top ten reach 72.3%. This means the field is concentrated at the top with a long tail of smaller filers behind it, rather than being evenly distributed across many companies.
Filing peaked in 2019 at 43 records and has since settled to a lower, comparatively flat level; the last complete-year comparison, 2021 to 2024, shows a -8% shift from 12 to 11 records. Because publication typically lags filing by around 18 months, the 2025 and 2026 figures are still incomplete and should not be read as evidence of decline. The honest read is a mature field holding steady rather than one in retreat.
Beyond the expected A21D baking and A23L food classes, which cover 54.5% and 39.8% of the 332 records respectively, a large share of filings also sit in A61K medicinal preparations (36.7%) and A61P therapeutic activity (18.1%). This reflects heavy overlap between food-process claims on lactic acid bacteria starters and health or therapeutic claims on the same microbial strains, so a search limited to food classes alone will miss a meaningful part of the relevant art.
CA3258861A1, filed by Il Granaio Delle Idee S.r.l. and published in January 2024, claims a processing aid combining a food-grade carrier with microcapsules of viable lactic acid bacteria, where the microcapsules use a gellable biopolymer casing and are defined by specific average size and mechanical compressive strength ranges. It targets a narrow but concrete implementation: encapsulated starter culture delivery for dough preparation, not sourdough fermentation broadly. Anyone working on encapsulated starter delivery systems should compare their microcapsule size and strength specifications against this filing directly.
The lower-density IPC branches relative to the corpus give the clearest signal: A61Q cosmetic use sits at only 12.0% of the 332 records and C12P fermentation and enzymatic synthesis at 13.0%, both well below the 54.5% seen in core baking claims. Combined with the fact that co-assignee collaboration is limited to just 10 pairs in this dataset, there is room for both new claim positions in under-filed technical branches and for new research partnerships modelled on the existing ingredient-company-and-university pairings.
Research Sourdough and Biological Leavening in depth with Eureka
Go past this page: query the whole sourdough and biological leavening corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.